LIGI ABRAHAM: Open Payments
NPI 1376158295 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 30 payments from 12 companies in 2025. Trend: 2023 $54 · 2024 $407 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $219 |
| Caris MPI, Inc. | 2 | $210 |
| AstraZeneca Pharmaceuticals LP | 2 | $143 |
| HISTOSONICS, INC. | 1 | $135 |
| Merck Sharp & Dohme LLC | 4 | $111 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $68 |
| Exelixis Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Deciphera Pharmaceuticals Inc. | 1 | $17 |
Products named: Zynyz, MI CANCER SEEK, KEYTRUDA, LUTATHERA, Stivarga, CABOMETYX, FRUZAQLA, QINLOCK.
Industry payments across OK — which companies pay providers there.
